ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakugawa, T.
Right arrow Articles by Kohno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakugawa, T.
Right arrow Articles by Kohno, S.
Eur Respir J 2004; 24:57-65
Copyright ©ERS Journals Ltd 2004


Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis

T. Kakugawa1, H. Mukae1, T. Hayashi2, H. Ishii1, K. Abe1, T. Fujii1, H. Oku3, M. Miyazaki1, J. Kadota4 and S. Kohno1

1 Second Dept of Internal Medicine, Nagasaki University School of Medicine, 2 Dept of Pathology, Nagasaki University Hospital, Nagasaki, and 3 Medicinal Biology 3 Division, Discovery Research Laboratories, Shionogi & Co. Ltd, Osaka, and 4 Second Dept of Internal Medicine, Oita Medical University, Oita, Japan

CORRESPONDENCE: H. Mukae, Second Dept of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Fax: 81 958497285. E-mail: hmukae@net.nagasaki-u.ac.jp

Keywords: Heat shock protein 47, myofibroblast, pirfenidone, pulmonary fibrosis, {alpha}-smooth muscle actin

Received: October 28, 2003
Accepted March 9, 2004

This study was supported in part by a research grant from the Ministry of Education, Science, Sports and Culture of Japan.

Heat shock protein (HSP) 47, a collagen-specific molecular chaperone, is involved in the processing and/or secretion of procollagen. The present study was undertaken to investigate whether treatment with the antifibrotic drug pirfenidone attenuates the bleomycin (BL)-induced overexpression of HSP47 in the lungs.

Male ICR mice were intravenously injected with BL or saline (SA). Pirfenidone or control drug (CD) was administered 14 days after commencement of BL or SA, and continued throughout the course of the experiment. The mice were randomly divided into three experimental groups: 1) SA-treated with CD (SA group); 2) BL-treated with CD (BL group); and 3) BL-treated with pirfenidone (pirfenidone group).

Lungs of the pirfenidone group showed a marked reduction of fibrotic lesions compared with the corresponding BL group. Immunohistochemical studies showed that BL treatment significantly increased the number of macrophages, myofibroblasts, HSP47-positive type II pneumocytes and HSP47-positive interstitial spindle-shaped cells. Treatment with pirfenidone significantly reduced the number of these cells compared with the corresponding BL group. Furthermore, treatment with pirfenidone significantly suppressed the BL-induced increase of the positive ratio of HSP47 and {alpha}-smooth muscle actin to interstitial spindle-shaped cells.

The present study results showed that pirfenidone inhibited heat shock protein 47-positive cells and myofibroblasts, the principal cells responsible for the accumulation and deposition of extracellular matrix seen in pulmonary fibrosis.




This article has been cited by other articles:


Home page
Therapeutic Advances in Respiratory DiseaseHome page
P. Rogliani, M. Mura, M. Assunta Porretta, and C. Saltini
Review: New perspectives in the treatment of idiopathic pulmonary fibrosis
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 75 - 93.
[Abstract] [PDF]


Home page
J. Immunol.Home page
N. Decologne, M. Kolb, P. J. Margetts, F. Menetrier, Y. Artur, C. Garrido, J. Gauldie, P. Camus, and P. Bonniaud
TGF-beta1 Induces Progressive Pleural Scarring and Subpleural Fibrosis
J. Immunol., November 1, 2007; 179(9): 6043 - 6051.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
S. Shi, J. Wu, H. Chen, H. Chen, J. Wu, and F. Zeng
Single- and Multiple-Dose Pharmacokinetics of Pirfenidone, an Antifibrotic Agent, in Healthy Chinese Volunteers
J. Clin. Pharmacol., October 1, 2007; 47(10): 1268 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Koide, Y. Nishikawa, S. Asada, C. M. Yamazaki, Y. Takahara, D. L. Homma, A. Otaka, K. Ohtani, N. Wakamiya, K. Nagata, et al.
Specific Recognition of the Collagen Triple Helix by Chaperone HSP47: II. THE HSP47-BINDING STRUCTURAL MOTIF IN COLLAGENS AND RELATED PROTEINS
J. Biol. Chem., April 21, 2006; 281(16): 11177 - 11185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.